CenterCenter website

Englander Institute for Precision Medicine

The Englander Institute for Precision Medicine is a large multi-disciplinary institute that uses precision medicine technologies and informatics to uncover the molecular mechanisms of disease and individualize disease treatment and prevention.

OEDirectorOlivier ElementoDirector of the Englander Institute for Precision Medicine

Top research areas

Translational & Clinical Science506 Cell & Molecular Biology495 Genetics, Genomics & Precision Medicine476

58 scholars8,329 publications

Spotlight

Prostate & Urologic Cancer

STScott T. Tagawa HBHimisha Beltran MJMichael J. Morris

Lancet (London, England) · 2026

Gastrointestinal Cancer

MAManish A Shah

Journal of clinical oncology : official journal of the American Society of Clinical Oncology · 2026

Lung Cancer

NKNasser K Altorki JLJeffrey L Port TWThomas William Bauer

The New England journal of medicine · 2023

View all 8,329 publications →

Scholars58 Publications8,329 Grants204

Showing 1–20 of 8,329 publications

Stereotactic arrhythmia radioablation: radiobiology, clinical evidence, and emerging applications.
FGFabiana Gregucci JNJohn Ng JWJim W. Cheung GTGeorge Thomas+4 more →SCSilvia Chiara Formenti
Frontiers in oncology · 2026
Safety and Feasibility of Single-Port Robotic Lung Cancer Resection: Initial United States Experience of 145 Consecutive Cases.
RHRichard Hawran JCJesse Codner OCOliver Chow SWSebron Wood Harrison+3 more →JVJonathan Villena-Vargas
The Annals of thoracic surgery · 2026
Blood-based PhenoAge may reflect disease burden rather than biological aging in cancer.
PJPatrick J. McCormick JSJoseph Scarpa JSJoshua S. Mincer
medRxiv : the preprint server for health sciences · 2026
Association of Clonal Hematopoiesis With Total and Cause-Specific Mortality Among Older Women.
PDPinkal Desai
JACC. Advances · 2026
A selective TNKS2 inhibitor for tumor-restricted WNT suppression.
KCKevan ChuSBSher BahadurBDBenjamin David Hopkins DHDavid Huggins LELukas Edward Dow
Nature chemical biology · 2026 · 1 citations
Author Correction: Applying Artificial Intelligence and machine learning in precision nutrition.
JFJulia Finkelstein FWFei Wang OEOlivier Elemento SMSaurabh Mehta
Nature communications · 2026
Grade Group 1 prostate cancer: indolent but not innocent.
FKFrancesca Khani MLMassimo Loda
BJU international · 2026
Single-port robotic lung resection: A comparison against the standard multiport platform.
JVJonathan Villena-Vargas JCJesse Codner SAShaikha Al-Thani OCOliver Chow+3 more →JLJeffrey L Port
JTCVS open · 2026
Hijacking the Message: Insights from Targeting mRNA Export and Translation in AML.
MLMonica L Guzman
International journal of molecular sciences · 2026
Circulating tumor DNA in breast cancer in 2027: advancing liquid biopsy and molecular monitoring.
MCMassimo Cristofanilli CRCarolina Reduzzi ENEleonora Nicolo
Current opinion in obstetrics & gynecology · 2026
MYC drives endothelial transformation and dedifferentiation in angiosarcoma.
SRShahin Rafii PCPing Chi
bioRxiv : the preprint server for biology · 2026
Circulating tumor DNA in body fluids for molecular characterization of cancers beyond tissue and blood.
MCMassimo Cristofanilli
iScience · 2026
Recent trends in race and ethnicity reporting in breast surgery journals.
LALisa Ann Newman
Breast cancer research and treatment · 2026
Functional stratification of YWHAZ variants explains distinct neurodevelopmental disorders.
OAOmar Abdul-Rahman
American journal of human genetics · 2026
Patch Testing for Implanted Medical Device-Related Delayed Hypersensitivity Reactions: Retrospective Analysis of North American Contact Dermatitis Group Data, 2016-2022.
JZJonathan Zippin
Dermatitis : contact, atopic, occupational, drug · 2026
Actionable genetic landscape and dynamics in circulating DNA from 12,827 patients with metastatic breast cancer.
MCMassimo Cristofanilli
Nature communications · 2026
Effects of refined carbohydrates on immune markers after weight loss on a very-low-carbohydrate diet: A randomized controlled feeding trial.
YSYushu ShiINIsaac NathooBDBenjamin David Hopkins
Cell press blue · 2026
Recovering anaerobic bacterial genomes in saliva, tumour and blood whole genome sequencing data from patients with prostate cancer.
MLMassimo Loda FKFrancesca Khani LMLuigi Marchionni LQLucio Queiroz BDBrian D. Robinson
NPJ biofilms and microbiomes · 2026
Analysis of quality-adjusted time without symptoms or toxicity (Q-TWiST) in patients with metastatic hormone-sensitive prostate cancer from the ARASENS trial.
CSCora Sternberg
European journal of cancer (Oxford, England : 1990) · 2026
HER2 phenotyping of CTCs in breast cancer: a comparison across the spectrum of tissue HER2 expression level.
LFLorenzo Foffano ENEleonora Nicolo NBNadia Bayou MSMara Serena Serafini+2 more →CRCarolina Reduzzi
The journal of liquid biopsy · 2026

Englander Institute for Precision Medicine

[177Lu]Lu-PSMA-617 in patients with PSMA-positive metastatic androgen pathway modulator-naive/sensitive prostate cancer (PSMAddition): a phase 3 randomised, controlled trial

Immunotherapy and Targeted Therapy for Advanced Gastroesophageal Cancer: ASCO Living Guideline, Version 2026.1.2

Lobar or Sublobar Resection for Peripheral Stage IA Non-Small-Cell Lung Cancer